AAAAAA

   
Results: 1-18 |
Results: 18
Lithuanian haemophilia A and B registry comprising phenotypic and genotypic data
Authors: Ivaskevicius, V Jurgutis, R Rost, S Muller, A Schmitt, C Wulff, K Herrmann, FH Muller, CR Schwaab, R Oldenburg, J
Citation: V. Ivaskevicius et al., Lithuanian haemophilia A and B registry comprising phenotypic and genotypic data, BR J HAEM, 112(4), 2001, pp. 1062-1070
Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease
Authors: Schneppenheim, R Budde, U Obser, T Brassard, J Mainusch, K Ruggeri, ZM Schneppenheim, S Schwaab, R Oldenburg, J
Citation: R. Schneppenheim et al., Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease, BLOOD, 97(7), 2001, pp. 2059-2066
NovoSeven (R) in immune tolerance therapy
Authors: Brackmann, HH Effenberger, E Hess, L Schwaab, R Oldenburg, J
Citation: Hh. Brackmann et al., NovoSeven (R) in immune tolerance therapy, BL COAG FIB, 11, 2000, pp. S39-S44
Application of the TaqMan-PCR for genotyping of the prothrombin G20210A mutation and of the thermolabile methylenetetrahydrofolate reductase mutation
Authors: Happich, D Madlener, K Schwaab, R Hanfland, P Potzsch, B
Citation: D. Happich et al., Application of the TaqMan-PCR for genotyping of the prothrombin G20210A mutation and of the thermolabile methylenetetrahydrofolate reductase mutation, THROMB HAEM, 84(1), 2000, pp. 144-145
Molecular genetics in haemophilia A
Authors: Oldenburg, J Brackmann, HB Hanfland, P Schwaab, R
Citation: J. Oldenburg et al., Molecular genetics in haemophilia A, VOX SANGUIN, 78, 2000, pp. 33-38
Antibodies to factor VIII in hemophilia A patients
Authors: Brackmann, HH Schwaab, R Effenberger, W Hess, L Hanfland, P Oldenburg, J
Citation: Hh. Brackmann et al., Antibodies to factor VIII in hemophilia A patients, VOX SANGUIN, 78, 2000, pp. 187-190
Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family
Authors: Schwaab, R Oldenburg, J Kemball-Cook, G Albert, T Juhler, C Hanfland, P Ingerslev, J
Citation: R. Schwaab et al., Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family, BR J HAEM, 109(3), 2000, pp. 523-528
De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism
Authors: Oldenburg, J Rost, S El-Maarri, O Leuer, M Olek, K Muller, CR Schwaab, R
Citation: J. Oldenburg et al., De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism, BLOOD, 96(8), 2000, pp. 2805-2806
De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism
Authors: Oldenburg, J Rost, S El-Maarri, O Leuer, M Olek, K Muller, CR Schwaab, R
Citation: J. Oldenburg et al., De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism, BLOOD, 96(8), 2000, pp. 2905-2906
A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIIIC1 domain reduce factor VIII binding to von Willebrand factor
Authors: Jacquemin, M Lavend'homme, R Benhida, A Vanzieleghem, B d'Oiron, R Lavergne, JM Brackmann, HH Schwaab, R VandenDriessche, T Chuah, MKL Hoylaerts, M Gilles, JGG Peerlinck, K Vermylen, J Saint-Remy, JMR
Citation: M. Jacquemin et al., A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIIIC1 domain reduce factor VIII binding to von Willebrand factor, BLOOD, 96(3), 2000, pp. 958-965
A human antibody directed to the factor VIIIC1 domain inhibits factor VIIIcofactor activity and binding to von Willebrand factor
Authors: Jacquemin, M Benhida, A Peerlinck, K Desqueper, B Elst, LV Lavend'homme, R d'Oiron, R Schwaab, R Bakkus, M Thielemans, K Gilles, JG Vermylen, J Saint-Remy, JM
Citation: M. Jacquemin et al., A human antibody directed to the factor VIIIC1 domain inhibits factor VIIIcofactor activity and binding to von Willebrand factor, BLOOD, 95(1), 2000, pp. 156-163
Highly sensitive and species-specific assay for quantification of human transgene expression levels
Authors: Haack, A Poller, W Schneider-Rasp, S Thalheimer, P Schmitt, C Hanfland, P Brackmann, HH Schwaab, R
Citation: A. Haack et al., Highly sensitive and species-specific assay for quantification of human transgene expression levels, HAEMOPHILIA, 5(5), 1999, pp. 334-339
Analysis of expression kinetics and activity of a new B-domain truncated and full-length FVIII protein in three different cell lines
Authors: Haack, A Schmitt, C Poller, W Oldenburg, J Hanfland, P Brackmann, HH Schwaab, R
Citation: A. Haack et al., Analysis of expression kinetics and activity of a new B-domain truncated and full-length FVIII protein in three different cell lines, ANN HEMATOL, 78(3), 1999, pp. 111-116
Allelic discrimination of factor V Leiden using a 5 ' nuclease assay
Authors: Happich, D Schwaab, R Hanfland, P Hoernschemeyer, D
Citation: D. Happich et al., Allelic discrimination of factor V Leiden using a 5 ' nuclease assay, THROMB HAEM, 82(4), 1999, pp. 1294-1296
Utilization of previously treated patients (PTPs), noninfected patients (NIPs), and previously untreated patients (PUPs) in the evaluation of new factor VIII and factor IX concentrates - Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and StandardizationCommittee of the International Society on Thrombosis and Haemostasis
Authors: White, GC DiMichele, D Mertens, K Negrier, C Peake, IR Prowse, C Schwaab, R Yoshioka, A Ingerslev, J
Citation: Gc. White et al., Utilization of previously treated patients (PTPs), noninfected patients (NIPs), and previously untreated patients (PUPs) in the evaluation of new factor VIII and factor IX concentrates - Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and StandardizationCommittee of the International Society on Thrombosis and Haemostasis, THROMB HAEM, 81(3), 1999, pp. 462-462
Induction of immune tolerance in haemophilia A inhibitor patients by the 'Bonn protocol': Predictive parameter for therapy duration and outcome
Authors: Oldenburg, J Schwaab, R Brackmann, HH
Citation: J. Oldenburg et al., Induction of immune tolerance in haemophilia A inhibitor patients by the 'Bonn protocol': Predictive parameter for therapy duration and outcome, VOX SANGUIN, 77, 1999, pp. 49-54
Detection of mutations and polymorphisms in clotting factors by denaturinggradient gel electrophoresis
Authors: Schwaab, R Schmidt, W
Citation: R. Schwaab et W. Schmidt, Detection of mutations and polymorphisms in clotting factors by denaturinggradient gel electrophoresis, METH MOL M, 31, 1999, pp. 85-104
Immune tolerance induction: a role for recombinant activated factor VII (rFVIIa)?
Authors: Brackmann, HH Effenberger, W Hess, L Schwaab, R Oldenburg, J
Citation: Hh. Brackmann et al., Immune tolerance induction: a role for recombinant activated factor VII (rFVIIa)?, EUR J HAEMA, 61, 1998, pp. 18-23
Risultati: 1-18 |